Related Experiment Video
Updated: Feb 16, 2026
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Recent advances in the management of non-small cell lung cancer
Samira Shojaee1, Patrick Nana-Sinkam1
1Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, USA.
Abstract:
Lung cancer is the number one cause of cancer-related death in both men and women. However, over the last few years, we have witnessed improved outcomes that are largely attributable to early detection, increased efforts in tobacco control, improved surgical approaches, and the development of novel targeted therapies. Currently, there are several novel therapies in clinical practice, including those targeting actionable mutations and more recently immunotherapeutic agents. Immunotherapy represents the most significant step forward in eradicating this deadly disease. Given the ever-changing landscape of lung cancer management, here we present an overview of the most recent advances in the management of non-small cell lung cancer.
Insights
Lung cancer survival is improving due to early detection and new treatments like targeted therapies and immunotherapy. This overview covers recent advances in non-small cell lung cancer management.
Area of Science:
- Oncology
- Pulmonology
- Medical Research
Background:
- Lung cancer remains a leading cause of cancer mortality worldwide.
- Recent years show improved patient outcomes attributed to advancements in detection and treatment.
- Key progress includes early detection, tobacco control, surgical techniques, and novel therapies.
Purpose of the Study:
- To provide an overview of recent therapeutic advances in non-small cell lung cancer (NSCLC).
- To highlight the impact of targeted therapies and immunotherapies in clinical practice.
- To discuss the evolving landscape of lung cancer management.
Main Methods:
- Literature review of recent clinical studies and therapeutic developments.
- Analysis of current treatment strategies for non-small cell lung cancer.
- Synthesis of information on targeted therapies and immunotherapeutic agents.
Main Results:
- Novel targeted therapies are now available for specific actionable mutations in lung cancer.
- Immunotherapeutic agents represent a significant breakthrough in treating lung cancer.
- The management of non-small cell lung cancer is rapidly evolving with new treatment options.
Conclusions:
- Early detection and novel therapies, particularly immunotherapy, are improving lung cancer outcomes.
- Continued research and clinical application of new treatments are crucial for combating lung cancer.
- This overview summarizes key recent advances in non-small cell lung cancer treatment.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers